AllI · Sterile fill-finish capacityII · Stoppers, syringes & drug-contact componentsIII · Pharmaceutical glass & vialsIV · Bioprocessing consumables & resinsV · API & small-molecule reshoringVI · CDMO capacity & the China exodusVII · Peptide & oligonucleotide manufacturingVIII · Sterile injectables & shortage economicsIX · Analytical instruments & QC releaseX · Private giants & exposure vehicles
| Ticker | Name | Tier ↓ | Quote | Mkt cap | 6M | Chokepoints |
|---|---|---|---|---|---|---|
| A | Agilent Technologies, Inc. | core | $173.07-0.5% | $37.0B | +49.8% | peptides-oligos · instruments-qc |
| DHR | Danaher Corporation | core | $230.50+0.3% | $128.0B | +30.0% | bioprocessing · instruments-qc |
| TMO | Thermo Fisher Scientific Inc. | core | $673.82-0.4% | $180.0B | +43.5% | fill-finish · bioprocessing · api-reshoring · cdmo-capacity · instruments-qc |
| WAT | Waters Corporation | core | $453.67-0.4% | $36.0B | +46.4% | instruments-qc |
| BMXMF | bioMerieux S.A. | watch | $99.63+0.1% | $8.6B | -5.5% | instruments-qc |
| CRL | Charles River Laboratories International, Inc. | watch | $345.37+1.7% | $8.9B | +103.4% | cdmo-capacity · instruments-qc |
| MTD | Mettler-Toledo International | watch | $1670.29-0.9% | $23.0B | +30.2% | instruments-qc |
Quote shows the latest price and daily change; the 6M column is the total return over that window. Quotes delayed up to 15 minutes; tiers are editorial conviction, not ratings. Click a column header to sort.